PITTSBURGH, July 9, 2018 /PRNewswire/ -- GNC (NYSE: GNC), a leading global specialty health, wellness and performance retailer,will release results for the second quarter of 2018 before the market opens on July 26, 2018. A webcast and conference call to discuss the results will be held at 8:30 am Eastern Time that
To participate on the live call listeners in North America may dial 1-800-263-0877 and international listeners may dial 1-323-794-2094. It is encouraged that callers dial in 5-10 minutes prior to the start of the call. In addition, a live webcast of the call will be available on www.gnc.com via the Investor Relations section under "About GNC." A replay of this webcast will be available through August 9, 2018.
GNC Holdings, Inc. (NYSE: GNC), headquartered in Pittsburgh, PA, is a leading global specialty health, wellness and performance retailer.
GNC connects customers to their best selves by offering a premium assortment of heath, wellness and performance products, including protein, performance supplements, weight management supplements, vitamins, herbs and greens, wellness supplements, health and beauty, food and drink and other general merchandise. This assortment features proprietary GNC and nationally recognized third-party brands.
GNC's diversified, multi-channel business model generates revenue from product sales through company-owned retail stores, domestic and international franchise activities, third-party contract manufacturing, e-commerce and corporate partnerships. As of March 31, 2018, GNC had approximately 8,900 locations, of which approximately 6,700 retail locations are in the United States (including approximately 2,400 Rite Aid franchise store-within-a-store locations) and franchise operations in approximately 50 countries.
View original content:http://www.prnewswire.com/news-releases/gnc-second-quarter-2018-earnings-release-webcast-and-conference-call-scheduled-for-july-26-2018-300676155.html
SOURCE GNC Holdings, Inc.
Subscribe to our Free Newsletters!
DOOR syndrome is a rare genetic disorder marked by deafness, short or absent fingernails, abnormal ...
Are you gluten intolerant? Stay away from gluten allergy and celiac disease by shifting to ...
Moxetumomab pasudotox-tdfk is used to treat hairy cell leukemia (a form of chronic lymphocytic ...View All